A couple of stocks that have been hot buys this year are Regeneron Pharmaceuticals (NASDAQ: REGN) and T-Mobile US (NASDAQ: TMUS) . These businesses defied the bear market as their strong fundamentals and continued growth gave investors reason to rally around their stocks. Unlike the S&P 500 , which is down about 17% this year, these two stocks have generated positive returns of 15% or more.
But there are metrics to suggest these two stocks have more growth to come. Here's a closer look at why both of these stocks can still soar higher in 2023.
Biotech company Regeneron focuses on creating "life-transforming medicines," and that can be good for the bottom line as well as for patients. Its business centers around its eyecare medication, Eylea (aflibercept ) , which today generates the bulk of Regeneron's revenue.
For further details see:
2 Market-Beating Stocks That Can Continue Rising in 2023